- Home
- TALO vs KROS Comparison
TALO vs KROS Comparison
Compare TALO & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALO
- KROS
- Stock Information
- Founded
- TALO 2011
- KROS 2015
- Country
- TALO United States
- KROS United States
- Employees
- TALO N/A
- KROS N/A
- Industry
- TALO Oil & Gas Production
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- TALO Energy
- KROS Health Care
- Exchange
- TALO Nasdaq
- KROS Nasdaq
- Market Cap
- TALO 1.5B
- KROS 558.9M
- IPO Year
- TALO N/A
- KROS 2020
- Fundamental
- Price
- TALO $9.00
- KROS $13.45
- Analyst Decision
- TALO Buy
- KROS Buy
- Analyst Count
- TALO 8
- KROS 13
- Target Price
- TALO $14.25
- KROS $20.63
- AVG Volume (30 Days)
- TALO 4.0M
- KROS 603.2K
- Earning Date
- TALO 08-06-2025
- KROS 08-06-2025
- Dividend Yield
- TALO N/A
- KROS N/A
- EPS Growth
- TALO N/A
- KROS N/A
- EPS
- TALO 0.14
- KROS 0.11
- Revenue
- TALO $2,055,748,000.00
- KROS $214,713,000.00
- Revenue This Year
- TALO N/A
- KROS $5,006.76
- Revenue Next Year
- TALO N/A
- KROS N/A
- P/E Ratio
- TALO $59.96
- KROS $123.44
- Revenue Growth
- TALO 31.54
- KROS 91657.70
- 52 Week Low
- TALO $6.23
- KROS $9.12
- 52 Week High
- TALO $12.71
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- TALO 51.52
- KROS 43.42
- Support Level
- TALO $8.19
- KROS $13.24
- Resistance Level
- TALO $8.79
- KROS $13.77
- Average True Range (ATR)
- TALO 0.36
- KROS 0.38
- MACD
- TALO -0.07
- KROS -0.04
- Stochastic Oscillator
- TALO 29.13
- KROS 28.00
About TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.